Phoebe Leggett-Stevenson

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Assessment of human immunity to A/H3N2 influenza subclade K during 2025 emergence.

Assessment of human immunity to A/H3N2 influenza subclade K during 2025 emergence.

Journal: EBioMedicine

Published: March 16, 2026

Third exposure to COVID-19 infection or vaccination differentially impacts T cell responses.

Third exposure to COVID-19 infection or vaccination differentially impacts T cell responses.

Journal: The Journal of infection

Published: July 18, 2025

Immunogenicity of three-dose COVID-19 vaccines in people living with multiple sclerosis.

Immunogenicity of three-dose COVID-19 vaccines in people living with multiple sclerosis.

Journal: BMJ neurology open

Published: June 11, 2025

Investigation of Influenza A(H5N1) Virus Neutralization by Quadrivalent Seasonal Vaccines, United Kingdom, 2021-2024.

Investigation of Influenza A(H5N1) Virus Neutralization by Quadrivalent Seasonal Vaccines, United Kingdom, 2021-2024.

Journal: Emerging infectious diseases

Published: May 29, 2025

Recombinant infectious bronchitis virus containing mutations in non-structural proteins 10, 14, 15, and 16 and within the macrodomain provides complete protection against homologous challenge.

Recombinant infectious bronchitis virus containing mutations in non-structural proteins 10, 14, 15, and 16 and within the macrodomain provides complete protection against homologous challenge.

Journal: Journal of virology

Published: February 27, 2025

Improved Resolution of Influenza Vaccination Responses With High-Throughput Live Virus Microneutralisation.

Improved Resolution of Influenza Vaccination Responses With High-Throughput Live Virus Microneutralisation.

Journal: Influenza and other respiratory viruses

Published: December 06, 2024

Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeutics.

Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeutics.

Journal: Vaccine

Published: December 04, 2024

Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study.

Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study.

Journal: The Lancet. Infectious diseases

Published: April 11, 2024

Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign.

Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign.

Journal: Lancet (London, England)

Published: January 05, 2024

The spike protein of the apathogenic Beaudette strain of avian coronavirus can elicit a protective immune response against a virulent M41 challenge.

The spike protein of the apathogenic Beaudette strain of avian coronavirus can elicit a protective immune response against a virulent M41 challenge.

Journal: PloS one

Published: November 08, 2023

SARS-CoV-2 mucosal neutralising immunity after vaccination.

SARS-CoV-2 mucosal neutralising immunity after vaccination.

Journal: The Lancet. Infectious diseases

Published: August 25, 2023

A Temperature-Sensitive Recombinant of Avian Coronavirus Infectious Bronchitis Virus Provides Complete Protection against Homologous Challenge.

A Temperature-Sensitive Recombinant of Avian Coronavirus Infectious Bronchitis Virus Provides Complete Protection against Homologous Challenge.

Journal: Journal of virology

Published: August 16, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026